Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02365597
Title An Efficacy and Safety Study of JNJ-42756493 in Participants With Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

urinary system cancer

Therapies

Erdafitinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.